LAFAYETTE, LA / ACCESS Newswire / October 22, 2026 / (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its Third Quarter 2026 Earnings Conference Call on Thursday, November 5, 2026, at 11:00 a.Interested parties may participate in the call by dialing:877-407-6176 (US Toll-Free)+1 201-689-8451 (International)Live Audio Webcast: https://event.
Investors need to pay close attention to VMD stock based on the movements in the options market lately.
LAFAYETTE, LA / ACCESS Newswire / September 24, 2026 / (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that Michael Moore, President of Viemed, has adopted an automatic securities disposition plan (the "ASDP") relating to common shares of the Company.Under applicable securities laws, insiders are subject to limits on their ability to sell shares.
Viemed Healthcare’s updated analyst model now places fair value at $12.50, compared with the previous $11.00 estimate, which signals a reset in how the stock is being framed. Supportive analysts link this change to Viemed Healthcare’s position in home respiratory care and its exposure to a broader mix of equipment, while more cautious voices point to near term profitability pressures and a tighter margin of safety. As you read on, you will see how these shifting views shape the evolving...
Viemed Healthcare (NASDAQ:VMD) outlined its growth strategy, product diversification and capital allocation priorities at the Midwest IDEAS Conference, emphasizing its focus on providing in-home care for patients with complex respiratory conditions. Chief Executive Officer Casey Hoyt said complex r
This is the newest page. Registered accounts read further back.